SlideShare a Scribd company logo
1 of 35
ANTI-AMOEBIC DRUGS
Dr.RENJU.S.RAVI MD
AMOEBIASIS
infection with Entamoeba histolytica.
transmitted through GIT.
has two stages of development: cyst
and trophozoite.
Cysts → small intestine → little
trophozoites (ileocecum)
AMOEBIASIS
cysts (colon) — asymptomatic intestinal
infection, source of infection
trophozoites (tissues ) — intestinal
amoebiasis
→ extra intestinal infection
Intestinal amoebiasis :
amoebic ulcers a/c dysentery(blood,mucus in
stools)
C/c int. amoebiasis  vague abd.symptoms,
amoeboma
Extra intestinal d/s
Liver abscess
Rare- lung, spleen, kidney, brain
CLASSFICATION
Tissue Amoebiasis
*Both intestinal & extra intestinal
Nitroimidazoles – Metronidazole , Tinidazole ,
Secnidazole , Ornidazole
Alkaloids - Emetine , Hydroemetine
* Extra intestinal amoebiasis only - Chloroquine
 Luminal amoebiasis
Amide –Diloxanide furoate
8-Hydroxy quinolones –Quinidochlor
Antibiotics – Tetracycline,Paromomycin
Metronidazole
 Prototype drug introduced in 1959
 Bactericidal against Giardia lamblia,
anaerobic bacteria - Bacteroides fragilis,
Fusobacterium, Clostridium
perfringes/difficile, Helicobacter pylori,
Anaerobic Streptococci.
Does not affect aerobic bacteria.
MOA
• Not clearly understood
 Enters microorganism by diffusion - Nitro
group reduced to a highly reactive nitro radical
- DNA damaged Cytotoxicity.
 High selective anaerobic action – interference
with electron transportation from NADPH or
other reduced substrates
 • Also inhibits cell mediated immunity
 • Induce mutagenesis
 • Cause radio-sensitization
Metronidazole
Pharmacokinetics
• Completely absorbed from intestine
• Wide distribution in body.t ½ - 8hrs.
• Therapeutic concentrations in -Vaginal
secretions ,Semen ,Saliva, CSF
• Route of administration – oral &
parenteral
Metronidazole
Broad spectrum cidal action for
protozoa
1. Anti-amoebiasis: kills E histolytic
trophozoites but not cysts. Treatment of
all tissue infections with E histolytic. No
effect against luminal parasites and so
must be used with a luminal amoebicide
to ensure eradication of the infection.
2. Anti-trichomoniasis
3. Anti-anaerobic bacteria
4. Anti-giardiasis
Metronidazole
 Pseudomembranous colitis, Ulcerative
gingivitis, H.pylori, Peptic ulcer disease, Guinea
worm infestation.
 Adverse Drug Reactions
• Frequent - Anorexia, nausea, METALLIC TASTE,
abdominal cramps, disulfiram reaction.
• Less frequent - Headache, glossitis, dry mouth,
dizziness, rashes, transient neutropenia.
• On prolonged administration - Peripheral
neuropathy, CNS effects.
Tinidazole
 long t ½ ,slower metabolism, long DOA, OD
dosing.
Higher cure rates in amoebiasis.
Lower s/e metallic taste ,nausea, rash.
USES -
 Amoebiasis – 2g od X 3 d
 Tricho, giardiasis- 2g single dose
 Anaerobic infection –
Px -2 g single dose for colorectal surgeries
Tx – 2g  0.5 g bd X 5 days
 H pylori- 500 mg bd X 2 wks in triple therapy
 Secnidazole : longest t ½ [17-29 hrs]
2 g single dose but for hepatic amoebiasis 1.5 gm
od X5 days
 Ornidazole –long t ½ ,similar to Tinidazole
 Satranidazole –
better tolerability
No disulfiram reaction
No acetamide metabolite [weak carcinogen]
Emetine and Dehydroemetine
Emetine - alkaloid from Cephaelis ipecacuanha.
 Dehydroemetine - a semisynthetic
analog[less cardiotoxic,less cumulative]
 are effective against tissue trophozoites of E
histolytica .
MOA
Inhibiting peptidyl-tRNA translocation →
inhibiting elongation of peptide chain →
inhibiting protein synthesis → interfering
cleavage and breeding of trophozoites
No action on cysts
PK
 Administered s/c (preferred) or im. (but never
i.v.)
Uses
 kills E histolytic trophozoites of histolytic tissues
but no effect against luminal cysts -- + luminal
amoebicide
 Rapid action.
 Given only till a/c sx subside ( not> 10 days)
 Cumulative in liver, kidney, spleen, lungs– 2nd
course only after 6 weeks
 Reserve drug for severe cases or metronidazole
resistant or intolerant.
 Also for liver fluke infection.
Adverse Effects
 low selectivity → also inhibits
protein synthesis of eukaryote.
 Toxicity increase with length of
therapy.
1. Local irritant: pain and tenderness in
the area of injection.
2. GIT : nausea, vomiting (central and
direct),abdominal cramps ,diarrhoea.
3. Cardiac toxicity: arrhythmias,
congestive heart failure, hypotension,
ECG changes–to avoid strict bed rest
during therapy, no exercise X 2mnths
4. Neuromuscular blockade: muscle
weakness and discomfort– myositis
like
 Not be used in patients with cardiac
or renal disease, in young children,
or in pregnancy.
Chloroquine
Kills trophozoites .
Chloroquine reaches high liver concentrations
→ treatment of amoebic liver abscess.
 Not effective in the treatment of intestinal or
other extrahepatic amoebiasis.
 nor in controlling the luminal cycle (cyst
passers). completely absorbed from the upper
intestine
Efficacy similar to emetine, but duration
of treatment is longer and relapses
frequent.
No resistance detected.
Dose for amoebic liver abscess: 600
mg (base) for 2 days  300 mg daily for
2-3 weeks.
DILOXANIDE
 Diloxanide furoate is a dichoroacetamide derivative.
 Highly effective luminal amoebicide: directly
kills trophozoites responsible for production of cysts
 Hydrolyzed in intestine  released Diloxanide is
absorbed. Diloxanide( weaker amoebicide): no
systemic antiamoebic activity despite its absorption.
 primarily metabolized by glucuronidation  urine.
 Effective for asymptomatic luminal
infections and cyst passers.
 used with a tissue amoebicide, usually
metronidazole.
Adverse Effects: flatulence, nausea,
abdominal cramps, rashes etc.
NITAZOXANIDE
 Salicylamide congener of anthelminthic Niclosamide.
Spectrum
 Cryptosporidium parvum
 G. intestinalis, E. histolytica, and T. vaginalis , other
protozoans.
Intestinal helminths: Hymenolepis nana, Trichuris
trichiura, Ascaris lumbricoides, Enterobius vermicularis,
Ancylostoma duodenale, Strongyloides stercoralis, and
the liver fluke Fasciola hepatica.
Anaerobic bacteria, including Clostridium spp. and H.
pylori.
 Antiviral activity  now undergoing clinical trials for the
treatment of hepatitis C.
PK
 Prodrug  tizoxanide
 PFOR inhibitor [essential enzyme p/w of electron
transport metabolism in anaerobic organisms]
 Conjugated in liver  bile and urine
USE
 Amoebic dysentery as luminal amoebicide
 Giardiasis, Cryptosporidiosis
ADR
Abd pain, vomiting, head ache…
PAROMOMYCIN
Aminoglycoside antibiotic.
Not significantly absorbed from the GIT.
Only as a luminal amoebicide and has no
effect against extra intestinal amoebic
infections.
inhibiting protein synthesis → kill
trophozoites.
inhibiting symbiosis flora → indirectly
inhibiting amoeba protozoa.
Uses
DOC for treating intestinal colonization with E.
histolytica.
Giardiasis in pregnant women, especially during
the first trimester, when metronidazole is
contraindicated and as an alternative agent for
metronidazole-resistant isolates of G.
intestinalis.
Dose - 500 mg orally three times daily for 10
days
 6.25% cream has been used to treat vaginal
trichomoniasis in patients who had failed
metronidazole therapy or could not receive
metronidazole.
 Leishmaniasis.
Adverse effects
 abdominal pain and cramping, epigastric pain,
nausea and vomiting, steatorrhea, and diarrhea.
Rarely, rash and headache.
8-HYDROXYQUINOLINES
against Entamoeba, Giardia, Trichomonas, some
fungi (dermatophytes, Candida) and some
bacteria.
USE
 Intestinal amoebiasis as alternatives to Diloxanide
furoate.
Other uses are--giardiasis; local treatment of
monilial and trichomonas vaginitis, fungal and
bacterial skin infections.
Diarrhoeal diseases
Di iodohydroxyquine safer drug
 ADR
 Nausea, transient loose and green stools, pruritus
etc. Goiter  prolonged medication.
 Iodism (furunculosis, inflammation of mucous
membranes) --due to chronic iodine overload.
 Prolonged/repeated use of high doses of
quiniodochlor caused a neuropathic syndrome
called 'subacute myelo-optic neuropathy' (SMON)
 India banned only for pediatric patients,
[blindness]. Banned in other countries.
Tetracyclines
 Directly inhibit amoebae at high concentrations.
 Older tetracyclines are incompletely absorbed in
the small intestine, reach the colon in large
amounts and inhibit the bacterial flora with which
Entamoebae live symbiotically.
Thus, they indirectly reduce proliferation of
entamoebae in the colon and are used in chronic,
difficult to treat cases with only the luminal cycle
and little mucosal invasion.
 They are not good for acute dysentery and for
hepatic amoebiasis
 Tetracyclines lessen risk of
opportunistic infections
perforation
peritonitis
when given along with systemic amoebicide.
TREATMENT OF AMOEBIASIS
1. Invasive intestinal amoebiasis
• Metronidazole/ Tinidazole are DOC.
 Secnidazole, ornidazole,satranidazole are the
alternatives.
 Adjuvant measures for diarrhea and abdominal pain.
 Dehydroemetine is rarely used for most severe
cases faster symptomatic relief. discontinued
as soon as acute symptoms are controlled (2-3
days) and metronidazole started.
 Emetine may also be needed when
metronidazole is contraindicated or produces
rashes/neurotoxicity.
 This should be followed by a luminal
amoebicide to eradicate and to prevent carrier
(cyst passing) state.
2. Chronic intestinal amoebiasis/
asymptomatic cyst passers
 Diloxanide furoate –DOC
 Metronidazole/ Tinidazole- cure any latent
hepatic infection.
 A single course of a hydroxyquinoline not > 2
weeks may be used as third choice.
 A tetracycline with tissue amoebicide in cases
which fail to clear completely.
3. Hepatic amoebiasis
 Complete eradication of trophozoites from the liver is
essential to avoid relapses.
 Metronidazole / Tinidazole are the first choice drugs.
 Dehydroemetine is to be used only if metronidazole
cannot be given for one reason or the other.
 Abscess  aspirated.
 A luminal amoebicide must be given later to finish the
intestinal reservoir of infection.
THANK YOU

More Related Content

What's hot

What's hot (20)

Nasal decongestants
Nasal decongestantsNasal decongestants
Nasal decongestants
 
Leprosy; Antileprotic drugs
Leprosy; Antileprotic drugsLeprosy; Antileprotic drugs
Leprosy; Antileprotic drugs
 
Anti emetics
Anti  emeticsAnti  emetics
Anti emetics
 
Antitubercular Drug
Antitubercular Drug Antitubercular Drug
Antitubercular Drug
 
Emetics and antiemetics(VK)
Emetics and antiemetics(VK)Emetics and antiemetics(VK)
Emetics and antiemetics(VK)
 
Antileprotic drugs
Antileprotic drugsAntileprotic drugs
Antileprotic drugs
 
Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
 
Sulfonamide
SulfonamideSulfonamide
Sulfonamide
 
Antitussives
Antitussives Antitussives
Antitussives
 
Antimalarial drugs
Antimalarial drugsAntimalarial drugs
Antimalarial drugs
 
Chloroquine
ChloroquineChloroquine
Chloroquine
 
Isoniazid, Rifampicin, Pyrazinamide and Ethambutol
Isoniazid, Rifampicin, Pyrazinamide and EthambutolIsoniazid, Rifampicin, Pyrazinamide and Ethambutol
Isoniazid, Rifampicin, Pyrazinamide and Ethambutol
 
Sulfonamides
SulfonamidesSulfonamides
Sulfonamides
 
Antileprotic drugs - drdhriti
Antileprotic drugs - drdhritiAntileprotic drugs - drdhriti
Antileprotic drugs - drdhriti
 
Antiamoebic drugs
Antiamoebic drugsAntiamoebic drugs
Antiamoebic drugs
 
Sulphonamide
SulphonamideSulphonamide
Sulphonamide
 
Urinary Tract Infection
Urinary Tract InfectionUrinary Tract Infection
Urinary Tract Infection
 
Antiasthmatic drugs
Antiasthmatic drugsAntiasthmatic drugs
Antiasthmatic drugs
 
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
 
Aminoglycosides.pptx
Aminoglycosides.pptxAminoglycosides.pptx
Aminoglycosides.pptx
 

Similar to Anti Amoebic Drugs

Treatment of amoebiasis & giardiasis
Treatment of amoebiasis & giardiasisTreatment of amoebiasis & giardiasis
Treatment of amoebiasis & giardiasisNikhil Gupta
 
Antiamoebic and antiprotozoal drugs
Antiamoebic and antiprotozoal drugsAntiamoebic and antiprotozoal drugs
Antiamoebic and antiprotozoal drugsHarikrishnan A R
 
Antiamoebic and antiprotozoal drugs - drdhriti
Antiamoebic and antiprotozoal drugs - drdhritiAntiamoebic and antiprotozoal drugs - drdhriti
Antiamoebic and antiprotozoal drugs - drdhritihttp://neigrihms.gov.in/
 
Anti-amoebic & other antiprotozoal Drugs
Anti-amoebic & other antiprotozoal DrugsAnti-amoebic & other antiprotozoal Drugs
Anti-amoebic & other antiprotozoal DrugsDr.Arka Mondal
 
Amoebiasis dr.v.r.patkar
Amoebiasis dr.v.r.patkarAmoebiasis dr.v.r.patkar
Amoebiasis dr.v.r.patkarveerendrapatkar
 
ANTI AMOEBIC DRUGS ( drugs against amoebic action)
ANTI AMOEBIC DRUGS ( drugs against amoebic action)ANTI AMOEBIC DRUGS ( drugs against amoebic action)
ANTI AMOEBIC DRUGS ( drugs against amoebic action)Teena42750
 
Helminthiasis
HelminthiasisHelminthiasis
HelminthiasisR Nadaf
 
ANTIAMOEBIC AGENTS.pptx
ANTIAMOEBIC AGENTS.pptxANTIAMOEBIC AGENTS.pptx
ANTIAMOEBIC AGENTS.pptxEdwardOwuor3
 
Antiprotozoal drugs pharmacology zirgham
Antiprotozoal drugs pharmacology zirghamAntiprotozoal drugs pharmacology zirgham
Antiprotozoal drugs pharmacology zirghamZirgi Rana
 
Anthelmintic drugs sam
Anthelmintic drugs   samAnthelmintic drugs   sam
Anthelmintic drugs samSamya Sayantan
 
Antihelminthiasis.pptx
Antihelminthiasis.pptxAntihelminthiasis.pptx
Antihelminthiasis.pptxAnant Khot
 
Pharmcotherapy of helmintic infections
Pharmcotherapy of helmintic infectionsPharmcotherapy of helmintic infections
Pharmcotherapy of helmintic infectionsKarthiga M
 
Antiprotozoal for MBBS 2021
Antiprotozoal for MBBS 2021Antiprotozoal for MBBS 2021
Antiprotozoal for MBBS 2021Pravin Prasad
 

Similar to Anti Amoebic Drugs (20)

Antiamoebic agents
Antiamoebic agentsAntiamoebic agents
Antiamoebic agents
 
Treatment of amoebiasis & giardiasis
Treatment of amoebiasis & giardiasisTreatment of amoebiasis & giardiasis
Treatment of amoebiasis & giardiasis
 
Antiamoebic and antiprotozoal drugs
Antiamoebic and antiprotozoal drugsAntiamoebic and antiprotozoal drugs
Antiamoebic and antiprotozoal drugs
 
Antiamoebic and antiprotozoal drugs - drdhriti
Antiamoebic and antiprotozoal drugs - drdhritiAntiamoebic and antiprotozoal drugs - drdhriti
Antiamoebic and antiprotozoal drugs - drdhriti
 
Anti-amoebic & other antiprotozoal Drugs
Anti-amoebic & other antiprotozoal DrugsAnti-amoebic & other antiprotozoal Drugs
Anti-amoebic & other antiprotozoal Drugs
 
Amoebiasis dr.v.r.patkar
Amoebiasis dr.v.r.patkarAmoebiasis dr.v.r.patkar
Amoebiasis dr.v.r.patkar
 
Antiprotozoal drugs
Antiprotozoal drugsAntiprotozoal drugs
Antiprotozoal drugs
 
ANTI AMOEBIC DRUGS ( drugs against amoebic action)
ANTI AMOEBIC DRUGS ( drugs against amoebic action)ANTI AMOEBIC DRUGS ( drugs against amoebic action)
ANTI AMOEBIC DRUGS ( drugs against amoebic action)
 
12. anti amoebiais
12. anti amoebiais12. anti amoebiais
12. anti amoebiais
 
Anti ameobic drugs
Anti ameobic drugs Anti ameobic drugs
Anti ameobic drugs
 
Anti Ameobic Drugs
Anti Ameobic DrugsAnti Ameobic Drugs
Anti Ameobic Drugs
 
Helminthiasis
HelminthiasisHelminthiasis
Helminthiasis
 
ANTIAMOEBIC AGENTS.pptx
ANTIAMOEBIC AGENTS.pptxANTIAMOEBIC AGENTS.pptx
ANTIAMOEBIC AGENTS.pptx
 
Antiprotozoal drugs pharmacology zirgham
Antiprotozoal drugs pharmacology zirghamAntiprotozoal drugs pharmacology zirgham
Antiprotozoal drugs pharmacology zirgham
 
Anthelmintic drugs sam
Anthelmintic drugs   samAnthelmintic drugs   sam
Anthelmintic drugs sam
 
Antihelminthiasis.pptx
Antihelminthiasis.pptxAntihelminthiasis.pptx
Antihelminthiasis.pptx
 
Antihelminthics
AntihelminthicsAntihelminthics
Antihelminthics
 
Pharmcotherapy of helmintic infections
Pharmcotherapy of helmintic infectionsPharmcotherapy of helmintic infections
Pharmcotherapy of helmintic infections
 
Antiprotozoal for MBBS 2021
Antiprotozoal for MBBS 2021Antiprotozoal for MBBS 2021
Antiprotozoal for MBBS 2021
 
Antiprototozoal drugs
Antiprototozoal drugsAntiprototozoal drugs
Antiprototozoal drugs
 

More from Dr Renju Ravi

Gastro seminar TDM of biologics in ibd
Gastro seminar TDM of biologics in ibdGastro seminar TDM of biologics in ibd
Gastro seminar TDM of biologics in ibdDr Renju Ravi
 
Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)Dr Renju Ravi
 
Newer anti-platelets final.
Newer anti-platelets final.Newer anti-platelets final.
Newer anti-platelets final.Dr Renju Ravi
 
Pleiotropic effects of_statins
Pleiotropic effects of_statinsPleiotropic effects of_statins
Pleiotropic effects of_statinsDr Renju Ravi
 
Drug utilization studies
Drug utilization studiesDrug utilization studies
Drug utilization studiesDr Renju Ravi
 
Causality assessment scales
Causality assessment scalesCausality assessment scales
Causality assessment scalesDr Renju Ravi
 
Pharmacogenetics & Teratogenicity
Pharmacogenetics & TeratogenicityPharmacogenetics & Teratogenicity
Pharmacogenetics & TeratogenicityDr Renju Ravi
 
Oral anti coagulants ppt
Oral anti coagulants pptOral anti coagulants ppt
Oral anti coagulants pptDr Renju Ravi
 
Anti psychotic drugs
Anti psychotic drugsAnti psychotic drugs
Anti psychotic drugsDr Renju Ravi
 
Aprepitant Dr.Renju.S.Ravi
Aprepitant Dr.Renju.S.RaviAprepitant Dr.Renju.S.Ravi
Aprepitant Dr.Renju.S.RaviDr Renju Ravi
 

More from Dr Renju Ravi (20)

Gastro seminar TDM of biologics in ibd
Gastro seminar TDM of biologics in ibdGastro seminar TDM of biologics in ibd
Gastro seminar TDM of biologics in ibd
 
Off label use
Off label useOff label use
Off label use
 
Anti-anxiety drugs
Anti-anxiety drugsAnti-anxiety drugs
Anti-anxiety drugs
 
Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)Biotransformation (Drug Metabolism)
Biotransformation (Drug Metabolism)
 
Spare receptors
Spare receptorsSpare receptors
Spare receptors
 
Newer anti-platelets final.
Newer anti-platelets final.Newer anti-platelets final.
Newer anti-platelets final.
 
Pleiotropic effects of_statins
Pleiotropic effects of_statinsPleiotropic effects of_statins
Pleiotropic effects of_statins
 
Drug utilization studies
Drug utilization studiesDrug utilization studies
Drug utilization studies
 
Causality assessment scales
Causality assessment scalesCausality assessment scales
Causality assessment scales
 
Pharmacogenetics & Teratogenicity
Pharmacogenetics & TeratogenicityPharmacogenetics & Teratogenicity
Pharmacogenetics & Teratogenicity
 
B blockers
B blockersB blockers
B blockers
 
Oral anti coagulants ppt
Oral anti coagulants pptOral anti coagulants ppt
Oral anti coagulants ppt
 
Anti psychotic drugs
Anti psychotic drugsAnti psychotic drugs
Anti psychotic drugs
 
Alpha blockers
Alpha blockersAlpha blockers
Alpha blockers
 
Soft steroids
Soft  steroidsSoft  steroids
Soft steroids
 
Confidence interval
Confidence intervalConfidence interval
Confidence interval
 
Aprepitant Dr.Renju.S.Ravi
Aprepitant Dr.Renju.S.RaviAprepitant Dr.Renju.S.Ravi
Aprepitant Dr.Renju.S.Ravi
 
Diazepam poisoning
Diazepam poisoningDiazepam poisoning
Diazepam poisoning
 
Phase 3 protocol
Phase 3 protocolPhase 3 protocol
Phase 3 protocol
 
Bioassay
BioassayBioassay
Bioassay
 

Recently uploaded

world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 

Recently uploaded (20)

world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 

Anti Amoebic Drugs

  • 2. AMOEBIASIS infection with Entamoeba histolytica. transmitted through GIT. has two stages of development: cyst and trophozoite. Cysts → small intestine → little trophozoites (ileocecum)
  • 3. AMOEBIASIS cysts (colon) — asymptomatic intestinal infection, source of infection trophozoites (tissues ) — intestinal amoebiasis → extra intestinal infection
  • 4. Intestinal amoebiasis : amoebic ulcers a/c dysentery(blood,mucus in stools) C/c int. amoebiasis  vague abd.symptoms, amoeboma Extra intestinal d/s Liver abscess Rare- lung, spleen, kidney, brain
  • 5. CLASSFICATION Tissue Amoebiasis *Both intestinal & extra intestinal Nitroimidazoles – Metronidazole , Tinidazole , Secnidazole , Ornidazole Alkaloids - Emetine , Hydroemetine * Extra intestinal amoebiasis only - Chloroquine  Luminal amoebiasis Amide –Diloxanide furoate 8-Hydroxy quinolones –Quinidochlor Antibiotics – Tetracycline,Paromomycin
  • 6. Metronidazole  Prototype drug introduced in 1959  Bactericidal against Giardia lamblia, anaerobic bacteria - Bacteroides fragilis, Fusobacterium, Clostridium perfringes/difficile, Helicobacter pylori, Anaerobic Streptococci. Does not affect aerobic bacteria.
  • 7. MOA • Not clearly understood  Enters microorganism by diffusion - Nitro group reduced to a highly reactive nitro radical - DNA damaged Cytotoxicity.  High selective anaerobic action – interference with electron transportation from NADPH or other reduced substrates  • Also inhibits cell mediated immunity  • Induce mutagenesis  • Cause radio-sensitization
  • 8. Metronidazole Pharmacokinetics • Completely absorbed from intestine • Wide distribution in body.t ½ - 8hrs. • Therapeutic concentrations in -Vaginal secretions ,Semen ,Saliva, CSF • Route of administration – oral & parenteral
  • 9. Metronidazole Broad spectrum cidal action for protozoa 1. Anti-amoebiasis: kills E histolytic trophozoites but not cysts. Treatment of all tissue infections with E histolytic. No effect against luminal parasites and so must be used with a luminal amoebicide to ensure eradication of the infection. 2. Anti-trichomoniasis 3. Anti-anaerobic bacteria 4. Anti-giardiasis
  • 10. Metronidazole  Pseudomembranous colitis, Ulcerative gingivitis, H.pylori, Peptic ulcer disease, Guinea worm infestation.  Adverse Drug Reactions • Frequent - Anorexia, nausea, METALLIC TASTE, abdominal cramps, disulfiram reaction. • Less frequent - Headache, glossitis, dry mouth, dizziness, rashes, transient neutropenia. • On prolonged administration - Peripheral neuropathy, CNS effects.
  • 11. Tinidazole  long t ½ ,slower metabolism, long DOA, OD dosing. Higher cure rates in amoebiasis. Lower s/e metallic taste ,nausea, rash. USES -  Amoebiasis – 2g od X 3 d  Tricho, giardiasis- 2g single dose  Anaerobic infection – Px -2 g single dose for colorectal surgeries Tx – 2g  0.5 g bd X 5 days  H pylori- 500 mg bd X 2 wks in triple therapy
  • 12.  Secnidazole : longest t ½ [17-29 hrs] 2 g single dose but for hepatic amoebiasis 1.5 gm od X5 days  Ornidazole –long t ½ ,similar to Tinidazole  Satranidazole – better tolerability No disulfiram reaction No acetamide metabolite [weak carcinogen]
  • 13. Emetine and Dehydroemetine Emetine - alkaloid from Cephaelis ipecacuanha.  Dehydroemetine - a semisynthetic analog[less cardiotoxic,less cumulative]  are effective against tissue trophozoites of E histolytica .
  • 14. MOA Inhibiting peptidyl-tRNA translocation → inhibiting elongation of peptide chain → inhibiting protein synthesis → interfering cleavage and breeding of trophozoites No action on cysts PK  Administered s/c (preferred) or im. (but never i.v.)
  • 15. Uses  kills E histolytic trophozoites of histolytic tissues but no effect against luminal cysts -- + luminal amoebicide  Rapid action.  Given only till a/c sx subside ( not> 10 days)  Cumulative in liver, kidney, spleen, lungs– 2nd course only after 6 weeks  Reserve drug for severe cases or metronidazole resistant or intolerant.  Also for liver fluke infection.
  • 16. Adverse Effects  low selectivity → also inhibits protein synthesis of eukaryote.  Toxicity increase with length of therapy. 1. Local irritant: pain and tenderness in the area of injection. 2. GIT : nausea, vomiting (central and direct),abdominal cramps ,diarrhoea.
  • 17. 3. Cardiac toxicity: arrhythmias, congestive heart failure, hypotension, ECG changes–to avoid strict bed rest during therapy, no exercise X 2mnths 4. Neuromuscular blockade: muscle weakness and discomfort– myositis like  Not be used in patients with cardiac or renal disease, in young children, or in pregnancy.
  • 18. Chloroquine Kills trophozoites . Chloroquine reaches high liver concentrations → treatment of amoebic liver abscess.  Not effective in the treatment of intestinal or other extrahepatic amoebiasis.  nor in controlling the luminal cycle (cyst passers). completely absorbed from the upper intestine
  • 19. Efficacy similar to emetine, but duration of treatment is longer and relapses frequent. No resistance detected. Dose for amoebic liver abscess: 600 mg (base) for 2 days  300 mg daily for 2-3 weeks.
  • 20. DILOXANIDE  Diloxanide furoate is a dichoroacetamide derivative.  Highly effective luminal amoebicide: directly kills trophozoites responsible for production of cysts  Hydrolyzed in intestine  released Diloxanide is absorbed. Diloxanide( weaker amoebicide): no systemic antiamoebic activity despite its absorption.  primarily metabolized by glucuronidation  urine.
  • 21.  Effective for asymptomatic luminal infections and cyst passers.  used with a tissue amoebicide, usually metronidazole. Adverse Effects: flatulence, nausea, abdominal cramps, rashes etc.
  • 22. NITAZOXANIDE  Salicylamide congener of anthelminthic Niclosamide. Spectrum  Cryptosporidium parvum  G. intestinalis, E. histolytica, and T. vaginalis , other protozoans. Intestinal helminths: Hymenolepis nana, Trichuris trichiura, Ascaris lumbricoides, Enterobius vermicularis, Ancylostoma duodenale, Strongyloides stercoralis, and the liver fluke Fasciola hepatica. Anaerobic bacteria, including Clostridium spp. and H. pylori.  Antiviral activity  now undergoing clinical trials for the treatment of hepatitis C.
  • 23. PK  Prodrug  tizoxanide  PFOR inhibitor [essential enzyme p/w of electron transport metabolism in anaerobic organisms]  Conjugated in liver  bile and urine USE  Amoebic dysentery as luminal amoebicide  Giardiasis, Cryptosporidiosis ADR Abd pain, vomiting, head ache…
  • 24. PAROMOMYCIN Aminoglycoside antibiotic. Not significantly absorbed from the GIT. Only as a luminal amoebicide and has no effect against extra intestinal amoebic infections. inhibiting protein synthesis → kill trophozoites. inhibiting symbiosis flora → indirectly inhibiting amoeba protozoa.
  • 25. Uses DOC for treating intestinal colonization with E. histolytica. Giardiasis in pregnant women, especially during the first trimester, when metronidazole is contraindicated and as an alternative agent for metronidazole-resistant isolates of G. intestinalis. Dose - 500 mg orally three times daily for 10 days
  • 26.  6.25% cream has been used to treat vaginal trichomoniasis in patients who had failed metronidazole therapy or could not receive metronidazole.  Leishmaniasis. Adverse effects  abdominal pain and cramping, epigastric pain, nausea and vomiting, steatorrhea, and diarrhea. Rarely, rash and headache.
  • 27. 8-HYDROXYQUINOLINES against Entamoeba, Giardia, Trichomonas, some fungi (dermatophytes, Candida) and some bacteria. USE  Intestinal amoebiasis as alternatives to Diloxanide furoate. Other uses are--giardiasis; local treatment of monilial and trichomonas vaginitis, fungal and bacterial skin infections. Diarrhoeal diseases Di iodohydroxyquine safer drug
  • 28.  ADR  Nausea, transient loose and green stools, pruritus etc. Goiter  prolonged medication.  Iodism (furunculosis, inflammation of mucous membranes) --due to chronic iodine overload.  Prolonged/repeated use of high doses of quiniodochlor caused a neuropathic syndrome called 'subacute myelo-optic neuropathy' (SMON)  India banned only for pediatric patients, [blindness]. Banned in other countries.
  • 29. Tetracyclines  Directly inhibit amoebae at high concentrations.  Older tetracyclines are incompletely absorbed in the small intestine, reach the colon in large amounts and inhibit the bacterial flora with which Entamoebae live symbiotically. Thus, they indirectly reduce proliferation of entamoebae in the colon and are used in chronic, difficult to treat cases with only the luminal cycle and little mucosal invasion.
  • 30.  They are not good for acute dysentery and for hepatic amoebiasis  Tetracyclines lessen risk of opportunistic infections perforation peritonitis when given along with systemic amoebicide.
  • 31. TREATMENT OF AMOEBIASIS 1. Invasive intestinal amoebiasis • Metronidazole/ Tinidazole are DOC.  Secnidazole, ornidazole,satranidazole are the alternatives.  Adjuvant measures for diarrhea and abdominal pain.
  • 32.  Dehydroemetine is rarely used for most severe cases faster symptomatic relief. discontinued as soon as acute symptoms are controlled (2-3 days) and metronidazole started.  Emetine may also be needed when metronidazole is contraindicated or produces rashes/neurotoxicity.  This should be followed by a luminal amoebicide to eradicate and to prevent carrier (cyst passing) state.
  • 33. 2. Chronic intestinal amoebiasis/ asymptomatic cyst passers  Diloxanide furoate –DOC  Metronidazole/ Tinidazole- cure any latent hepatic infection.  A single course of a hydroxyquinoline not > 2 weeks may be used as third choice.  A tetracycline with tissue amoebicide in cases which fail to clear completely.
  • 34. 3. Hepatic amoebiasis  Complete eradication of trophozoites from the liver is essential to avoid relapses.  Metronidazole / Tinidazole are the first choice drugs.  Dehydroemetine is to be used only if metronidazole cannot be given for one reason or the other.  Abscess  aspirated.  A luminal amoebicide must be given later to finish the intestinal reservoir of infection.